Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

RDNT US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

RadNet, Inc.(RDNT US)

$76.04-2.042.61%Ext:$73.64-2.403.15%(Market Closed · 00:55:35 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

RDNT US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

RadNet, Inc.(RDNT US)

$76.04-2.042.61%Ext:$73.64-2.403.15%(Market Closed · 00:55:35 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

RadNet, Inc. — Company Profile

RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.

Sector
Health Care
Industry
Health Care Equipment & Supplies
Exchange
UQ
CEO
Howard G. Berger
Headquarters
Los Angeles, CA, US
IPO Date
Jan 3, 1997
Employees
9,060
Website
www.radnet.com

Key Metrics

Price
$69.93
Market Cap
$5.50B
Revenue (TTM)
$575.63M
Net Income (TTM)
$-33466000.00
EPS (TTM)
-0.43
P/E (TTM)
-387.46
P/B (TTM)
5.09
Dividend Yield
0.00%
ROE (TTM)
-3.10%
ROA (TTM)
-0.86%
Operating Margin
-2.85%
Beta
0.98

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.

Website
www.radnet.com
Location
Los Angeles, CA, US
Phone310 478 7808
Employees9,060
CEOHoward G. Berger
Sector
Health Care
Industry
Health Care Equipment & Supplies
IPO DateJan 3, 1997

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(1.3K)

Expand
  • Form 4Patel Mital12 Nov
  • Form 144Patel Mital12 Nov
  • 10-QQ3ended 30 Sept 20269 Nov
  • 8-KPRESS RELEASE9 Nov
  • 8-KPRESS RELEASE DATED OCTOBER 26, 202626 Oct
  • 8-KOther Events14 Aug
  • 424B7PROSPECTUS14 Aug
  • SC 13G/ARadNet, Inc.14 Aug
  • 10-QQ2ended 30 Jun 202610 Aug
  • 8-KPRESS RELEASE DATED AUGUST 9, 202610 Aug
  • Form 4SWARTZ DAVID L22 Jun
  • Form 4Wesdorp Cornelis18 Jun
  • Form 4Berger Howard G18 Jun
  • Form 144SWARTZ DAVID L18 Jun
  • Form 144Wesdorp Cornelis16 Jun
  • Form 4Forthuber Stephen M16 Jun
  • Form 144Forthuber Stephen M15 Jun
  • 8-KPRESS RELEASE DATED JUNE 10, 202610 Jun
  • Form 4SWARTZ DAVID L3 Jun
  • Form 4SPURLOCK GREGORY E.3 Jun

News

  • Why RadNet (RDNT) is a Top Momentum Stock for the Long-Term10:51AM
  • RadNet's Imaging Growth Can Fund DeepHealth's Hospital Rollout12 Nov
  • RadNet: 3 Key Takeaways for Long-Term Investors10 Nov
  • RadNet: A 'Buy' On Sizable Q3 Beat And Value-Generating M&A10 Nov
  • RadNet, Inc. (RDNT) Q3 2026 Earnings Call Transcript9 Nov
  • RadNet Q3 Earnings Call Highlights9 Nov
  • RadNet (RDNT) Reports Q3 Earnings: What Key Metrics Have to Say9 Nov
  • RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges8 Nov
  • RadNet (RDNT) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates5 Nov
  • RadNet (RDNT) Soars 9.7%: Is Further Upside Left in the Stock?5 Nov
  • RadNet (RDNT) Reports Next Week: Wall Street Expects Earnings Growth2 Nov
  • RadNet, Inc. Announces Date of its Third Quarter 2026 Financial Results Conference Call29 Oct
  • RadNet to Buy ONRAD in $350M Deal, Expanding Hospital Radiology Services27 Oct
  • RadNet, Inc. (RDNT) M&A Call Transcript27 Oct
  • RadNet, Inc. Announces Agreement to Acquire ONRAD, Inc.26 Oct
  • Head-To-Head Review: RadNet (NASDAQ:RDNT) vs. Joint (NASDAQ:JYNT)22 Oct
  • New Study Shows DeepHealth AI Could Help Avoid Nearly One in Five Prostate Biopsies8 Oct
  • RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals1 Oct
  • Engineers Gate Manager LP Acquires New Holdings in RadNet, Inc. $RDNT24 Sep
  • RadNet, Inc. (RDNT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript16 Sep

Mentions in Filings

  • … nue to continue to increase as we add insurance payors and our scan volumes increase. *Cost of Revenue*. Direct cost of revenue is comprised of hosting and software costs, field support, UCSF royalty cost, partner fees (<strong>RadNet</strong>), and credit card fees. Total cost of revenue was $53,238 for the nine months ended September 30, 2026, compared to $52,214 for the same period in 2025, an increase of $1,024, or 2.0%. Cost of revenue increased at a subst …
    Aclarion, Inc.RadNet, Inc.·10-Q - Quarterly report Q3·Q3 26·5 Nov
  • … re as follows: | | | | --- | --- | | Selected Companies | EV/NTM EBITDA Multiple | | Addus HomeCare Corporation | 10.0x | | Aveanna Healthcare Holdings, Inc. | 11.3x | | BrightSpring Health Services, Inc. | 16.2x | | Chemed Corporation | 12.5x | | Encompass Health Corporation | 9.8x | | Guardian Pharmacy Services, Inc. | 19.0x | | <strong>RadNet, Inc.</strong> | 15.3x | | Surgery Partners, Inc. | 10.2x | | U.S. Physical Therapy, Inc. | 12.6x | | Median | 12.5x | …
    Option Care Health, Inc.RadNet, Inc.·DEFM14A - Definitive proxy statement (merger)·Q4 26·9 Nov
  • … % | | 08/2031 | | 9,103.5 | 8,974.8 | 8,966.9 | (2)(8)(13) | | | Project Ruby Ultimate Parent Corp. | First lien senior secured loan | 6.74% | SOFR (M) | 2.75% | | 03/2028 | | 110,578.0 | 110,613.7 | 110,834.5 | (2) | | | <strong>Radnet</strong> Management, Inc. | First lien senior secured loan | 6.07% | SOFR (Q) | 2.25% | | 04/2031 | | 5,174.0 | 5,184.6 | 5,188.2 | (2)(6) | | | Raven Acquisition Holdings, LLC (11) | First lien senior secured loan | 6.72% | SOFR …
    ARES STRATEGIC INCOME FUNDRadNet, Inc.·424B3 - Prospectus filing (Rule 424(b)(3))·Q4 26·6 Nov
  • … an | S+ | 2.75 | % | 11/2031 | 16,363 | 16,356 | 16,307 | 2.3 | % | | Project Ruby Ultimate Parent Corp. (dba Wellsky)(5) | First lien senior secured loan | S+ | 2.75 | % | 03/2028 | 11,945 | 11,947 | 11,929 | 1.7 | % | | <strong>RadNet</strong> Management, Inc.(6) | First lien senior secured loan | S+ | 2.00 | % | 04/2031 | 4,636 | 4,633 | 4,628 | 0.7 | % | | Raven Acquisition Holdings, LLC (dba R1 RCM)(6) | First lien senior secured loan | S+ | 3.00 | % | 11/20 …
    Blue Owl Capital Corp IIRadNet, Inc.·EX-99.1 - 10-Q - Quarterly report Q3·Q3 26·6 Nov
  • … % | | 08/2031 | | 9,103.5 | 8,974.8 | 8,966.9 | (2)(8)(13) | | | Project Ruby Ultimate Parent Corp. | First lien senior secured loan | 6.74% | SOFR (M) | 2.75% | | 03/2028 | | 110,578.0 | 110,613.7 | 110,834.5 | (2) | | | <strong>Radnet</strong> Management, Inc. | First lien senior secured loan | 6.07% | SOFR (Q) | 2.25% | | 04/2031 | | 5,174.0 | 5,184.6 | 5,188.2 | (2)(6) | | | Raven Acquisition Holdings, LLC (11) | First lien senior secured loan | 6.72% | SOFR …
    ARES STRATEGIC INCOME FUNDRadNet, Inc.·10-Q - Quarterly report Q3·Q3 26·6 Nov
  • … nits | Amortized Cost(2) | | Fair Value | | % of Members’ Equity (9) | | | Project Ruby Ultimate Parent Corp. (dba Wellsky)(5) | First lien senior secured loan | S+ | 2.75 | % | 03/2028 | 1,660 | 1,660 | | 1,658 | | | | | <strong>Radnet</strong> Management, Inc.(6) | First lien senior secured loan | S+ | 3.00 | % | 11/2031 | 7,754 | 7,722 | | 7,740 | | | | | Radnet Management, Inc.(6) | First lien senior secured loan | S+ | 2.00 | % | 04/2031 | 2,918 | 2,918 | | …
    Blue Owl Credit Income Corp.RadNet, Inc.·EX-99.1 - 10-Q - Quarterly report Q3·Q3 26·5 Nov

Key Stats

Trading

Px/Chg 1D$69.93 / +3.29%
Avg Volume885.37K
Beta0.98
Mkt Cap5.50B
FD Mkt Cap5.90B

Float

Shrs Out/Float78.63M / 70.36M
Short Float0.14%
Days to Cover7.89
Stock Repurchased$0.00

Current Valuation

EV7.25B
EV/EBITDA22.38
EV/Sales3.38
P/B5.09
P/S2.56
FCF Yield0.41%
ROE-3.10%
ROA-0.86%
Current Ratio1.17

Estimates

P/E-387.46
Est P/E0.00
Est EPS-0.14
Est PEG0.00

Valuation

Metric5Yr AvgMay '23May '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-953.13150.961,118.921,457.61-7,328.81-164.31
Price / Sales4.601.122.112.237.999.55
Price / Book Value4.774.835.404.514.015.09
Price / Free Cash Flow75.82-15.6176.9590.56-18.95246.16
ENTERPRISE VALUE METRICS
Enterprise Value5,232.63,151.84,737.25,291.05,732.97,250.1
Enterprise Value / Sales6.222.202.932.8910.4712.59
Enterprise Value / EBITDA66.4011.3216.1820.1541.02243.32
Enterprise Value / EBIT-41.8433.6045.8642.43146.83-477.89

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue11.6%1,315.11,430.11,616.61,829.72,040.2
Gross Income-17.1%191.8165.7221.4249.190.8
EBITDA-2.3%278.4278.5292.8262.5253.9
EBIT-1.4%107.793.8103.3124.7101.8
Net Income—24.710.73.02.8-18.7
EPS (Diluted)—0.460.170.050.04-0.25
BALANCE SHEET
Cash & ST Inv54.5%134.6127.8342.6740.0767.2
Total Assets16.2%2,058.52,433.92,690.53,286.73,758.6
Total Liabilities8.8%1,712.31,942.51,877.12,153.32,402.7
Total Shareholder Equity47.7%228.9333.0630.7902.31,089.9
CASH FLOW
Net Operating Cash Flow18.9%149.5146.4220.9233.0298.8
Cap Ex-85.4%-220.7-249.4-176.6-188.1-213.3
Free Cash Flow—-71.2-103.044.345.085.6

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)75.89
Basic Shares78.63
Market Cap5,967.2
Diluted Shares78.73
Fully Diluted Shares Outstanding78.73
Fully Diluted Market Cap5,974.5
+Consolidated Debt2,182.7
−In-the-Money Convertible Debt—
+Capital Leases850.2
+Operating Leases—
−Cash & Equivalents-726.3
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest298.0
+Pension Liabilities—
Enterprise Value7,721.5

Segment data

Revenue

by Products and services

  • Commercial Insurance159%
  • Medicare125%
  • Capitation Arrangements7%
  • Health Care, Other3%
  • Medicaid13%

Revenue

by Geography

  • United States98%
  • Non-us2%

Related companies

WuXi AppTec Co., Ltd.

WUXAY US

Natera, Inc.

NTRA US

Labcorp Holdings Inc.

LH US

Guardant Health, Inc.

GH US

WuXi XDC Cayman Inc

2268 HK

Caris Life Sciences, Inc.

CAI US

Sonic Healthcare Ltd / ADR

SKHHY US

GRAIL, Inc.

GRAL US

Joinn Laboratories(China)Co.,Ltd.

603127 CG

Sotera Health Co

SHC US

Vontier Corp

VNT US

DiaSorin S.p.A.

DSRLF US

RadNet, Inc. — Company Profile

RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.

Sector
Health Care
Industry
Health Care Equipment & Supplies
Exchange
UQ
CEO
Howard G. Berger
Headquarters
Los Angeles, CA, US
IPO Date
Jan 3, 1997
Employees
9,060
Website
www.radnet.com

Key Metrics

Price
$69.93
Market Cap
$5.50B
Revenue (TTM)
$575.63M
Net Income (TTM)
$-33466000.00
EPS (TTM)
-0.43
P/E (TTM)
-387.46
P/B (TTM)
5.09
Dividend Yield
0.00%
ROE (TTM)
-3.10%
ROA (TTM)
-0.86%
Operating Margin
-2.85%
Beta
0.98

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.

Website
www.radnet.com
Location
Los Angeles, CA, US
Phone310 478 7808
Employees9,060
CEOHoward G. Berger
Sector
Health Care
Industry
Health Care Equipment & Supplies
IPO DateJan 3, 1997

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(1.3K)

Expand
  • Form 4Patel Mital12 Nov
  • Form 144Patel Mital12 Nov
  • 10-QQ3ended 30 Sept 20269 Nov
  • 8-KPRESS RELEASE9 Nov
  • 8-KPRESS RELEASE DATED OCTOBER 26, 202626 Oct
  • 8-KOther Events14 Aug
  • 424B7PROSPECTUS14 Aug
  • SC 13G/ARadNet, Inc.14 Aug
  • 10-QQ2ended 30 Jun 202610 Aug
  • 8-KPRESS RELEASE DATED AUGUST 9, 202610 Aug
  • Form 4SWARTZ DAVID L22 Jun
  • Form 4Wesdorp Cornelis18 Jun
  • Form 4Berger Howard G18 Jun
  • Form 144SWARTZ DAVID L18 Jun
  • Form 144Wesdorp Cornelis16 Jun
  • Form 4Forthuber Stephen M16 Jun
  • Form 144Forthuber Stephen M15 Jun
  • 8-KPRESS RELEASE DATED JUNE 10, 202610 Jun
  • Form 4SWARTZ DAVID L3 Jun
  • Form 4SPURLOCK GREGORY E.3 Jun

News

  • Why RadNet (RDNT) is a Top Momentum Stock for the Long-Term10:51AM
  • RadNet's Imaging Growth Can Fund DeepHealth's Hospital Rollout12 Nov
  • RadNet: 3 Key Takeaways for Long-Term Investors10 Nov
  • RadNet: A 'Buy' On Sizable Q3 Beat And Value-Generating M&A10 Nov
  • RadNet, Inc. (RDNT) Q3 2026 Earnings Call Transcript9 Nov
  • RadNet Q3 Earnings Call Highlights9 Nov
  • RadNet (RDNT) Reports Q3 Earnings: What Key Metrics Have to Say9 Nov
  • RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges8 Nov
  • RadNet (RDNT) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates5 Nov
  • RadNet (RDNT) Soars 9.7%: Is Further Upside Left in the Stock?5 Nov
  • RadNet (RDNT) Reports Next Week: Wall Street Expects Earnings Growth2 Nov
  • RadNet, Inc. Announces Date of its Third Quarter 2026 Financial Results Conference Call29 Oct
  • RadNet to Buy ONRAD in $350M Deal, Expanding Hospital Radiology Services27 Oct
  • RadNet, Inc. (RDNT) M&A Call Transcript27 Oct
  • RadNet, Inc. Announces Agreement to Acquire ONRAD, Inc.26 Oct
  • Head-To-Head Review: RadNet (NASDAQ:RDNT) vs. Joint (NASDAQ:JYNT)22 Oct
  • New Study Shows DeepHealth AI Could Help Avoid Nearly One in Five Prostate Biopsies8 Oct
  • RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals1 Oct
  • Engineers Gate Manager LP Acquires New Holdings in RadNet, Inc. $RDNT24 Sep
  • RadNet, Inc. (RDNT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript16 Sep

Mentions in Filings

  • … nue to continue to increase as we add insurance payors and our scan volumes increase. *Cost of Revenue*. Direct cost of revenue is comprised of hosting and software costs, field support, UCSF royalty cost, partner fees (<strong>RadNet</strong>), and credit card fees. Total cost of revenue was $53,238 for the nine months ended September 30, 2026, compared to $52,214 for the same period in 2025, an increase of $1,024, or 2.0%. Cost of revenue increased at a subst …
    Aclarion, Inc.RadNet, Inc.·10-Q - Quarterly report Q3·Q3 26·5 Nov
  • … re as follows: | | | | --- | --- | | Selected Companies | EV/NTM EBITDA Multiple | | Addus HomeCare Corporation | 10.0x | | Aveanna Healthcare Holdings, Inc. | 11.3x | | BrightSpring Health Services, Inc. | 16.2x | | Chemed Corporation | 12.5x | | Encompass Health Corporation | 9.8x | | Guardian Pharmacy Services, Inc. | 19.0x | | <strong>RadNet, Inc.</strong> | 15.3x | | Surgery Partners, Inc. | 10.2x | | U.S. Physical Therapy, Inc. | 12.6x | | Median | 12.5x | …
    Option Care Health, Inc.RadNet, Inc.·DEFM14A - Definitive proxy statement (merger)·Q4 26·9 Nov
  • … % | | 08/2031 | | 9,103.5 | 8,974.8 | 8,966.9 | (2)(8)(13) | | | Project Ruby Ultimate Parent Corp. | First lien senior secured loan | 6.74% | SOFR (M) | 2.75% | | 03/2028 | | 110,578.0 | 110,613.7 | 110,834.5 | (2) | | | <strong>Radnet</strong> Management, Inc. | First lien senior secured loan | 6.07% | SOFR (Q) | 2.25% | | 04/2031 | | 5,174.0 | 5,184.6 | 5,188.2 | (2)(6) | | | Raven Acquisition Holdings, LLC (11) | First lien senior secured loan | 6.72% | SOFR …
    ARES STRATEGIC INCOME FUNDRadNet, Inc.·424B3 - Prospectus filing (Rule 424(b)(3))·Q4 26·6 Nov
  • … an | S+ | 2.75 | % | 11/2031 | 16,363 | 16,356 | 16,307 | 2.3 | % | | Project Ruby Ultimate Parent Corp. (dba Wellsky)(5) | First lien senior secured loan | S+ | 2.75 | % | 03/2028 | 11,945 | 11,947 | 11,929 | 1.7 | % | | <strong>RadNet</strong> Management, Inc.(6) | First lien senior secured loan | S+ | 2.00 | % | 04/2031 | 4,636 | 4,633 | 4,628 | 0.7 | % | | Raven Acquisition Holdings, LLC (dba R1 RCM)(6) | First lien senior secured loan | S+ | 3.00 | % | 11/20 …
    Blue Owl Capital Corp IIRadNet, Inc.·EX-99.1 - 10-Q - Quarterly report Q3·Q3 26·6 Nov
  • … % | | 08/2031 | | 9,103.5 | 8,974.8 | 8,966.9 | (2)(8)(13) | | | Project Ruby Ultimate Parent Corp. | First lien senior secured loan | 6.74% | SOFR (M) | 2.75% | | 03/2028 | | 110,578.0 | 110,613.7 | 110,834.5 | (2) | | | <strong>Radnet</strong> Management, Inc. | First lien senior secured loan | 6.07% | SOFR (Q) | 2.25% | | 04/2031 | | 5,174.0 | 5,184.6 | 5,188.2 | (2)(6) | | | Raven Acquisition Holdings, LLC (11) | First lien senior secured loan | 6.72% | SOFR …
    ARES STRATEGIC INCOME FUNDRadNet, Inc.·10-Q - Quarterly report Q3·Q3 26·6 Nov
  • … nits | Amortized Cost(2) | | Fair Value | | % of Members’ Equity (9) | | | Project Ruby Ultimate Parent Corp. (dba Wellsky)(5) | First lien senior secured loan | S+ | 2.75 | % | 03/2028 | 1,660 | 1,660 | | 1,658 | | | | | <strong>Radnet</strong> Management, Inc.(6) | First lien senior secured loan | S+ | 3.00 | % | 11/2031 | 7,754 | 7,722 | | 7,740 | | | | | Radnet Management, Inc.(6) | First lien senior secured loan | S+ | 2.00 | % | 04/2031 | 2,918 | 2,918 | | …
    Blue Owl Credit Income Corp.RadNet, Inc.·EX-99.1 - 10-Q - Quarterly report Q3·Q3 26·5 Nov

Key Stats

Trading

Px/Chg 1D$69.93 / +3.29%
Avg Volume885.37K
Beta0.98
Mkt Cap5.50B
FD Mkt Cap5.90B

Float

Shrs Out/Float78.63M / 70.36M
Short Float0.14%
Days to Cover7.89
Stock Repurchased$0.00

Current Valuation

EV7.25B
EV/EBITDA22.38
EV/Sales3.38
P/B5.09
P/S2.56
FCF Yield0.41%
ROE-3.10%
ROA-0.86%
Current Ratio1.17

Estimates

P/E-387.46
Est P/E0.00
Est EPS-0.14
Est PEG0.00

Valuation

Metric5Yr AvgMay '23May '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-953.13150.961,118.921,457.61-7,328.81-164.31
Price / Sales4.601.122.112.237.999.55
Price / Book Value4.774.835.404.514.015.09
Price / Free Cash Flow75.82-15.6176.9590.56-18.95246.16
ENTERPRISE VALUE METRICS
Enterprise Value5,232.63,151.84,737.25,291.05,732.97,250.1
Enterprise Value / Sales6.222.202.932.8910.4712.59
Enterprise Value / EBITDA66.4011.3216.1820.1541.02243.32
Enterprise Value / EBIT-41.8433.6045.8642.43146.83-477.89

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue11.6%1,315.11,430.11,616.61,829.72,040.2
Gross Income-17.1%191.8165.7221.4249.190.8
EBITDA-2.3%278.4278.5292.8262.5253.9
EBIT-1.4%107.793.8103.3124.7101.8
Net Income—24.710.73.02.8-18.7
EPS (Diluted)—0.460.170.050.04-0.25
BALANCE SHEET
Cash & ST Inv54.5%134.6127.8342.6740.0767.2
Total Assets16.2%2,058.52,433.92,690.53,286.73,758.6
Total Liabilities8.8%1,712.31,942.51,877.12,153.32,402.7
Total Shareholder Equity47.7%228.9333.0630.7902.31,089.9
CASH FLOW
Net Operating Cash Flow18.9%149.5146.4220.9233.0298.8
Cap Ex-85.4%-220.7-249.4-176.6-188.1-213.3
Free Cash Flow—-71.2-103.044.345.085.6

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)75.89
Basic Shares78.63
Market Cap5,967.2
Diluted Shares78.73
Fully Diluted Shares Outstanding78.73
Fully Diluted Market Cap5,974.5
+Consolidated Debt2,182.7
−In-the-Money Convertible Debt—
+Capital Leases850.2
+Operating Leases—
−Cash & Equivalents-726.3
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest298.0
+Pension Liabilities—
Enterprise Value7,721.5

Segment data

Revenue

by Products and services

  • Commercial Insurance159%
  • Medicare125%
  • Capitation Arrangements7%
  • Health Care, Other3%
  • Medicaid13%

Revenue

by Geography

  • United States98%
  • Non-us2%

Related companies

WuXi AppTec Co., Ltd.

WUXAY US

Natera, Inc.

NTRA US

Labcorp Holdings Inc.

LH US

Guardant Health, Inc.

GH US

WuXi XDC Cayman Inc

2268 HK

Caris Life Sciences, Inc.

CAI US

Sonic Healthcare Ltd / ADR

SKHHY US

GRAIL, Inc.

GRAL US

Joinn Laboratories(China)Co.,Ltd.

603127 CG

Sotera Health Co

SHC US

Vontier Corp

VNT US

DiaSorin S.p.A.

DSRLF US